Consumer health data is a subset of information linked or reasonably linkable to a consumer that identifies past, present, or future physical or mental health. Personal information is broader and includes any information that can identify or be linked to a consumer, such as an IP address or device identifier. In practice, the Act applies stricter handling rules to health related data than to general personal data.
Why the Act Draws a Stricter Line Around Health Data
The Washington My Health My Data Act treats consumer health data differently because the sensitivity is higher, the harm from misuse is more immediate, and the law is designed to curb collection and disclosure patterns that can reveal intimate health conditions. The practical difference is not just definition, it is regulatory handling: health-linked data triggers tighter consent, sharing, and deletion expectations.
A useful way to read the statute is that the label matters less than the data’s meaning and linkability. If data can reasonably be connected to a consumer and reveals physical or mental health status, it is pulled into the stricter category. That means teams cannot rely on generic privacy labeling to reduce obligations when the underlying signal is health-related.
For implementation context, the broader privacy baseline still matters. Personal information includes identifiers such as IP addresses, device identifiers, and other data that can be linked back to a consumer, but that breadth does not eliminate the narrower health-data bucket. The same record can be personal information in one respect and consumer health data in another, which is why classification needs to be done at the use-case and field level, not just at the record level.
How Classification Changes Collection, Sharing, and Deletion Decisions
The compliance difference becomes operational when a business decides what it may collect, why it collects it, and how long it keeps it. Personal information may be handled under general privacy controls, but consumer health data usually requires more cautious collection discipline, narrower sharing paths, and more explicit consumer-facing controls. The safe assumption is that health-related inferences deserve the strongest treatment available under the Act.
That distinction also affects downstream vendor and product design. A consumer profile that contains ordinary identifiers is not the same as a profile that reveals pregnancy status, mental health interests, fertility, or treatment signals. If a product team merges those fields together, the stricter health-data requirements can apply to the whole processing flow even when the raw identifiers would otherwise seem routine.
The most common mistake is to treat health data as just another privacy category because it sits inside a broader personal information program. In practice, the legal and operational risk rises when teams fail to separate ordinary identification data from health-sensitive attributes, especially in analytics, advertising, and tracking workflows.
Standards & Framework Alignment
This section maps relevant standards and security frameworks to the operational risks and controls described in this guidance.
NIST CSF 2.0, NIST SP 800-53 Rev 5, CIS Controls v8 and NIST SP 800-63 set the governance and control requirements practitioners need to meet.
| Framework | Control / Reference | Relevance |
|---|---|---|
| NIST CSF 2.0 | GV.PO-01 — Policy Expectations and Risk Governance | The Act requires policy-backed handling of sensitive consumer data. |
| PR.DS-01 — Data-at-Rest Protection | Sensitive health-linked data needs stronger protection than ordinary identifiers. | |
| PR.AC-03 — Access Enforcement | Limit who can access health-linked records and related identifiers. | |
| Recommendation — Define data-handling rules that separate general personal information from health-sensitive data. Apply stronger safeguards to datasets containing consumer health data. Restrict access to consumer health data on a need-to-know basis. | ||
| NIST SP 800-53 Rev 5 | AC-6 — Least Privilege | Least privilege supports tighter control over sensitive consumer health data. |
| PT-2 — PII Processing and Transparency | The question turns on how data classes are identified and handled. | |
| AR-4 — Privacy Monitoring and Auditing | Ongoing monitoring is needed to ensure health data is handled differently from general data. | |
| Recommendation — Limit access to health-related records to the minimum required roles. Classify consumer health data separately from broader personal information. Monitor processing flows to ensure health data receives stricter treatment. | ||
| CIS Controls v8 | 6.3 — Data Recovery | Data retention and deletion decisions matter when health data is collected. |
| 6.4 — Access Control Management | Different handling rules require tighter access management for health data. | |
| Recommendation — Set retention and deletion rules that reflect health-data sensitivity. Review and limit access to systems that store consumer health data. | ||
| NIST SP 800-63 | IAL1 — Identity Proofing Requirements | Consumer data programs often depend on how a consumer is linked to records. |
| Recommendation — Use appropriate identity-proofing strength before associating sensitive data with a consumer. | ||
Practitioner Guidance
What to verify: Classify fields by the meaning they reveal, not only by whether they identify someone. If a data element can reasonably be linked to a consumer and says something about health status, route it to the stricter handling path before product, marketing, or analytics teams reuse it.
Decision rule: When a dataset contains both general identifiers and health-linked signals, apply the health-data standard to the relevant processing activity, not just the individual column. That is the safer operational assumption when classification is mixed or uncertain.
What practitioners underestimate: The hardest part is often inference, not collection. A seemingly ordinary app event, browser action, or device signal can become consumer health data once it is tied to a health condition or treatment context.
Practitioner takeaway: Treat personal information as the broader category, but treat consumer health data as the higher-risk subset that can change consent, sharing, retention, and deletion decisions the moment health meaning becomes reasonably linkable.
Related resources from NHI Mgmt Group
- What is the difference between the New Zealand Privacy Act and GDPR for organisations handling personal information?
- What is the difference between consumer AI assistants and enterprise AI assistants for data privacy?
- What is the difference between consumer consent and the limits Maryland places on sensitive data processing?
- What is the difference between sensitive data and personal data?
